CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C, Santagata S, Napolitano M, Guardia F, Grimaldi A, Antignani E, Botti G, Consales C, Riccio A, Nanayakkara M, Barone MV, Caraglia M, Scala S.
Ieranò C, et al.
Cell Death Dis. 2014 Jul 3;5(7):e1310. doi: 10.1038/cddis.2014.269.
Cell Death Dis. 2014.
PMID: 24991762
Free PMC article.
The mTOR activation was specifically inhibited by CXCR4 antagonists (AMD3100, anti-CXCR4-12G5 and Peptide R, a newly developed CXCR4 antagonist) and CXCR7 antagonists (anti-CXCR7-12G8 and CCX771, CXCR7 inhibitor). To investigate the functional role of …
The mTOR activation was specifically inhibited by CXCR4 antagonists (AMD3100, anti-CXCR4-12G5 and Peptide R, a newly de …